Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.33 |
| ▸ | PTAFR | P25105 | 1/20 | 0.33 |
| ▸ | HTR1D | P28221 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.33 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.32 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7878849 | 0.87 | TSHR (0.44) | TSHR | |
| SCHEMBL2120609 | 0.85 | SMN1; SMN2 (0.53) | SMN1; SMN2ADRA1DPTAFRHTR1DHTR2C | |
| SCHEMBL27055217 | 0.83 | TSHR (0.44) | FABP3TSHR | |
| SCHEMBL28126982 | 0.82 | SMN1; SMN2 (0.34) | FABP3SMN1; SMN2TSHRADRA1DPTAFR | |
| SCHEMBL28093839 | 0.82 | FABP3 (0.38) | FABP3SMN1; SMN2TSHRADRA1DPTAFR | |
| SCHEMBL28853370 | 0.81 | FABP3 (0.45) | FABP3SMN1; SMN2TSHRADRA1DPTAFR | |
| SCHEMBL27983078 | 0.80 | TSHR (0.41) | TSHR | |
| SCHEMBL28572562 | 0.79 | FABP3 (0.34) | FABP3SMN1; SMN2TSHRADRA1DPTAFR | |
| SCHEMBL6673980 | 0.79 | BTN3A1 (0.40) | TSHR | |
| SCHEMBL2942450 | 0.79 | TSHR (0.46) | FABP3SMN1; SMN2TSHRCHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104119479-B | Biomimetic amphiphilic graft copolymer with cell membrane structure and preparation method thereof | 四川大学 | 2017-01-18 | — | — | CN | disclosed |
| US-8956602-B2 | Delivery of drugs | Landec, Inc. (US) | 2015-02-17 | — | — | US | disclosed |
| US-8524259-B2 | Systems and methods for delivery of materials | LANDEC CORPORATION (US) | 2013-09-03 | — | — | US | disclosed |
| US-8399007-B2 | Method for formulating a controlled-release pharmaceutical formulation | LANDEC CORPORATION (US) | 2013-03-19 | — | — | US | disclosed |
| EP-2502619-A2 | Systems and methods for delivery of materials | Landec Corporation (US) | 2012-09-26 | — | — | EP | disclosed |
| EP-2500015-A1 | Delivery of drugs | Landec Corporation (US) | 2012-09-19 | — | — | EP | disclosed |
| US-20110009571-A1 | SYSTEMS AND METHODS FOR DELIVERY OF MATERIALS | ALCON RESEARCH, LLC | 2011-01-13 | — | — | US | disclosed |
| EP-2229150-A2 | SYSTEMS AND METHODS FOR DELIVERY OF MATERIALS | LANDEC CORPORATION (US) | 2010-09-22 | — | — | EP | disclosed |
| US-20100210792-A1 | DRUG DELIVERY | LANDEC CORPORATION | 2010-08-19 | — | — | US | disclosed |
| US-20100004124-A1 | Systems and methods for delivery of materials for agriculture and aquaculture | LANDEC CORPORATION | 2010-01-07 | — | — | US | disclosed |
| US-20090263346-A1 | Systems and methods for delivery of drugs | LANDEC CORPORATION | 2009-10-22 | — | — | US | disclosed |
| US-20090252777-A1 | Method for formulating a controlled-release pharmaceutical formulation | LANDEC CORPORATION (US) | 2009-10-08 | — | — | US | disclosed |
| US-20090246155-A1 | Compositions and methods for personal care | LANDEC CORPORATION | 2009-10-01 | — | — | US | disclosed |
| EP-2101745-A1 | DELIVERY OF DRUGS | LANDEC CORPORATION (US) | 2009-09-23 | — | — | EP | disclosed |
| WO-2009073192-A2 | SYSTEMS AND METHODS FOR DELIVERY OF MATERIALS | LANDEC CORPORATION (US) | 2009-06-11 | — | — | WO | disclosed |
| US-20080269105-A1 | Delivery of drugs | ALCON RESEARCH, LLC | 2008-10-30 | — | — | US | disclosed |
| WO-2008070118-A9 | DRUG DELIVERY | LANDEC CORP (US) | 2008-09-18 | — | — | WO | disclosed |
| WO-2008070118-A1 | DRUG DELIVERY | LANDEC CORPORATION (US) | 2008-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090263346-A1 | Systems and methods for delivery of drugs | CYCS, CTRC, PPIC | FABP3 596/4885SMN1; SMN2 3647/4885TSHR 3231/4885 |
| US-20090246155-A1 | Compositions and methods for personal care | PPIC, CYCS, CTRC | FABP3 2168/4885SMN1; SMN2 3965/4885TSHR 3387/4885 |
| US-20100004124-A1 | Systems and methods for delivery of materials for agriculture and aquaculture | CYCS, PCCA, CRYAA | FABP3 901/4885SMN1; SMN2 3533/4885TSHR 4616/4885 |
| US-20080269105-A1 | Delivery of drugs | ABCB11, ABCB1, LPXN | FABP3 469/4885SMN1; SMN2 2086/4885TSHR 1074/4885 |
| US-20090252777-A1 | Method for formulating a controlled-release pharmaceutical formulation | LPXN, CYP3A7, LIPA | FABP3 1053/4885SMN1; SMN2 2379/4885TSHR 1441/4885 |
| US-20100210792-A1 | DRUG DELIVERY | ABCB11, VEGFA, ABCB1 | FABP3 378/4885SMN1; SMN2 1075/4885TSHR 1310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.